Protein kinase Cζ mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase

Cancer Research

Volumn 66, Issue 12, 2006, Pages 6296-6303

  Cohen, Ezra Eddy Wyssam ^a   Lingen, Mark W ^a   Zhu, Bangmin ^a   Zhu, Hongyan ^a   Straza, Michael Wayne ^a   Pierce, Carolyn ^a   Martin, Leslie E ^a   Rosner, Marsha Rich ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CHELERYTHRINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C ZETA;

ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER GROWTH; CARCINOMA; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA SYNTHESIS; DYSPLASIA; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HEAD AND NECK TUMOR; HUMAN; HUMAN CELL; KERATINOCYTE; MOUTH MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

ALKALOIDS; AMINO ACID SEQUENCE; BENZOPHENANTHRIDINES; BUTADIENES; CARCINOMA, SQUAMOUS CELL; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DNA, NEOPLASM; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; HEAD AND NECK NEOPLASMS; HUMANS; KERATINOCYTES; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; MOUTH MUCOSA; MOUTH NEOPLASMS; NITRILES; PHENANTHRIDINES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 33745699726     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-3139     Document Type: Article

References (21)

1. Berra E, Diaz-Meco MT, Dominguez I, et al. Protein kinase Cζ isoform is critical for mitogenic signal transduction. Cell 1993;74:555-63.
2. Corbit KC, Soh JW, Yoshida K, Eves EM. Weinstein IB, Rosner MR. Different protein kinase C isoforms determine growth factor specificity in neuronal cells. Mol Cell Biol 2000;20:5392-403.
3. Diaz-Meco MT, Dominguez I, Sanz L, et al. ζPKC induces phosphorylation and inactivation of IκB-α in vitro. EMBO J 1994;13:2842-8.
4. Dempsey EC, Newton AC, Mochly-Rosen D, et al. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 2000;279:L429-38.
5. Weichselbaum RR, Dunphy EJ, Beckett MA, et al. Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines. Head Neck 1989;11:437-42.
6. Gusterson BA, Anbazhagan R, Warren W, et al. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 1991;6:1785-9.
7. Magne N, Fischel JL, Dubreuil A, et al. Influence of epidermal growth factor receptor (EGFR), p53, and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 ("Iressa"). Br J Cancer 2002;86:1518-23.
8. Anrather J, Csizmadia V, Soares MP, Winkler H. Regulation of NF-κB RelA phosphorylation and transcriptional activity by p21(ras) and protein kinase Cζ in primary endothelial cells. J Biol Chem 1999;274:13594-603.
9. Corbit KC, Trakul N, Eves EM, Diaz B, Marshall M, Rosner MR. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J Biol Chem 2003;278:13061-8.
10. Hirai T, Chida K. Protein kinase Cζ (PKCζ): activation mechanisms and cellular functions. J Biochem (Tokyo) 2003;133:1-7.
11. Garcia-Paramio P, Cabrerizo Y, Bornancin F, Parker PJ. The broad specificity of dominant inhibitory protein kinase C mutants infers a common step in phosphorylation. Biochem J 1998;333:631-6.
12. Cai H, Smola U, Wixler V, et al. Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase. Mol Cell Biol 1997;17:732-41.
13. Wakeling AE, Guy SP, Woodburn JR, et al. ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Res 2002;62:5749-54.
14. Albanell J, Codony-Servat J, Rojo F, et al. Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor α expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. Cancer Res 2001;61:6500-10.
15. Chmura SJ, Dolan ME, Cha A, Mauceri HJ, Kufe DW, Weichselbaum RR. In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo. Clin Cancer Res 2000;6:737-42.
16. Reynolds NJ, Baldassare JJ, Henderson PA, et al. Translocation and downregulation of protein kinase C isoenzymes-α and -ε by phorbol ester and bryostatin-1 in human keratinocytes and fibroblasts. J Invest Dermatol 1994;103:364-9.
17. Fischer SM, Lee ML, Maldve RE, et al. Association of protein kinase C activation with induction of ornithine decarboxylase in murine but not human keratinocyte cultures. Mol Carcinog 1993;7:228-37.
18. Martinez-Gimeno C, Diaz-Meco MT, Dominguez I, Moscat J. Alterations in levels of different protein kinase C isotypes and their influence on behavior of squamous cell carcinoma of the oral cavity: εPKC, a novel prognostic factor for relapse and survival. Head Neck 1995;17:516-25.
19. Tosi L, Rinaldi E, Carinci F, et al. Akt, protein kinase C, mitogen-activated protein kinase phosphorylation status in head and neck squamous cell carcinoma. Head Neck 2005;27:130-7.
20. Sun R, Gao P, Chen L, et al. Protein kinase Cζ is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. Cancer Res 2005;65:1433-41.
21. Datta K, Li J, Bhattacharya R, Gasparian L, Wang E, Mukhopadhyay D. Protein kinase Cζ transactivates hypoxia-inducible factor α by promoting its association with p300 in renal cancer. Cancer Res 2004;64:456-62.